Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion ; volume:5 ; number:3 ; year:2020
Biomedicine hub ; 5, Heft 3 (2020)
- Creator
-
Horgan, Denis
Metspalu, Andres
Ouillade, Marie-Christine
Athanasiou, Dimitrios
Pasi, John
Adjali, Oumeya
Harrison, Patrick
Hermans, Cedric
Codacci-Pisanelli, Giovanni
Koeva, Jasmina
Szucs, Thomas
Cursaru, Viorica
Belina, Ivica
Bernini, Chiara
Zhuang, Suijie
McMahon, Stephen
Toncheva, Draga
Thum, Thomas
- DOI
-
10.1159/000511678
- URN
-
urn:nbn:de:101:1-2020123023142855641497
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Horgan, Denis
- Metspalu, Andres
- Ouillade, Marie-Christine
- Athanasiou, Dimitrios
- Pasi, John
- Adjali, Oumeya
- Harrison, Patrick
- Hermans, Cedric
- Codacci-Pisanelli, Giovanni
- Koeva, Jasmina
- Szucs, Thomas
- Cursaru, Viorica
- Belina, Ivica
- Bernini, Chiara
- Zhuang, Suijie
- McMahon, Stephen
- Toncheva, Draga
- Thum, Thomas
Other Objects (12)
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products and the Changing Role of Academia
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products
Advanced healthcare materials
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products and the Changing Role of Academia
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products
Advanced healthcare materials
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Advanced Therapy Medicinal Products and the Changing Role of Academia
Advanced Therapy Medicinal Products: Availability, Access and Expenditure in Italy
Development and Non-invasive Quality Assessment of Advanced Therapy Medicinal Products
Value-based pricing for advanced therapy medicinal products: emerging affordability solutions
The economics of manufacturing clinical-grade advanced therapy medicinal products (ATMPs)
Natural products in medicinal chemistry
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Challenges for Plasma-Derived Medicinal Products
Challenges for Plasma-Derived Medicinal Products